371 related articles for article (PubMed ID: 27721835)
41. Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus.
Zhu Y; Feng X
Stem Cell Res Ther; 2018 May; 9(1):149. PubMed ID: 29793537
[TBL] [Abstract][Full Text] [Related]
42. Mesenchymal stem cells transplantation mildly ameliorates experimental diabetic nephropathy in rats.
Zhou H; Tian HM; Long Y; Zhang XX; Zhong L; Deng L; Chen XH; Li XQ
Chin Med J (Engl); 2009 Nov; 122(21):2573-9. PubMed ID: 19951572
[TBL] [Abstract][Full Text] [Related]
43. Prostaglandin E2 Indicates Therapeutic Efficacy of Mesenchymal Stem Cells in Experimental Traumatic Brain Injury.
Kota DJ; Prabhakara KS; Toledano-Furman N; Bhattarai D; Chen Q; DiCarlo B; Smith P; Triolo F; Wenzel PL; Cox CS; Olson SD
Stem Cells; 2017 May; 35(5):1416-1430. PubMed ID: 28233425
[TBL] [Abstract][Full Text] [Related]
44. Enhancement of Functionality and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Cardiovascular Disease.
Yun CW; Lee SH
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813471
[TBL] [Abstract][Full Text] [Related]
45. [Overview and perspectives of mesenchymal stem cell therapy in intensive care medicine].
Espinoza F; Aliaga F; Crawford PL
Rev Med Chil; 2016 Feb; 144(2):222-31. PubMed ID: 27092677
[TBL] [Abstract][Full Text] [Related]
46. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.
Tögel F; Hu Z; Weiss K; Isaac J; Lange C; Westenfelder C
Am J Physiol Renal Physiol; 2005 Jul; 289(1):F31-42. PubMed ID: 15713913
[TBL] [Abstract][Full Text] [Related]
47. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
48. Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial.
Sun Q; Huang Z; Han F; Zhao M; Cao R; Zhao D; Hong L; Na N; Li H; Miao B; Hu J; Meng F; Peng Y; Sun Q
J Transl Med; 2018 Mar; 16(1):52. PubMed ID: 29514693
[TBL] [Abstract][Full Text] [Related]
49. Comparative effects of mesenchymal stem cell therapy in distinct stages of chronic renal failure.
Caldas HC; de Paula Couto TA; Fernandes IM; Baptista MA; Kawasaki-Oyama RS; Goloni-Bertollo EM; Braile DM; Abbud-Filho M
Clin Exp Nephrol; 2015 Oct; 19(5):783-9. PubMed ID: 25630669
[TBL] [Abstract][Full Text] [Related]
50. Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology.
Perico N; Casiraghi F; Remuzzi G
J Am Soc Nephrol; 2018 Feb; 29(2):362-375. PubMed ID: 29191959
[TBL] [Abstract][Full Text] [Related]
51. Recent advances in mesenchymal stem cell immunomodulation: the role of microvesicles.
Fierabracci A; Del Fattore A; Luciano R; Muraca M; Teti A; Muraca M
Cell Transplant; 2015; 24(2):133-49. PubMed ID: 24268069
[TBL] [Abstract][Full Text] [Related]
52. Intra renal arterial injection of autologous mesenchymal stem cells in an ovine model in the postischemic kidney.
Behr L; Hekmati M; Fromont G; Borenstein N; Noel LH; Lelievre-Pegorier M; Laborde K
Nephron Physiol; 2007; 107(3):p65-76. PubMed ID: 17940346
[TBL] [Abstract][Full Text] [Related]
53. Concise Review: Stem Cell Trials Using Companion Animal Disease Models.
Hoffman AM; Dow SW
Stem Cells; 2016 Jul; 34(7):1709-29. PubMed ID: 27066769
[TBL] [Abstract][Full Text] [Related]
54. Mesenchymal stem cell-based therapy in kidney transplantation.
Chen C; Hou J
Stem Cell Res Ther; 2016 Feb; 7():16. PubMed ID: 26852923
[TBL] [Abstract][Full Text] [Related]
55. The role of mesenchymal stem cells in the functional improvement of chronic renal failure.
Choi S; Park M; Kim J; Hwang S; Park S; Lee Y
Stem Cells Dev; 2009 Apr; 18(3):521-9. PubMed ID: 18647091
[TBL] [Abstract][Full Text] [Related]
56. Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.
Perico N; Casiraghi F; Gotti E; Introna M; Todeschini M; Cavinato RA; Capelli C; Rambaldi A; Cassis P; Rizzo P; Cortinovis M; Noris M; Remuzzi G
Transpl Int; 2013 Sep; 26(9):867-78. PubMed ID: 23738760
[TBL] [Abstract][Full Text] [Related]
57. Biology and therapeutic potential of mesenchymal stem cell-derived exosomes.
Xunian Z; Kalluri R
Cancer Sci; 2020 Sep; 111(9):3100-3110. PubMed ID: 32639675
[TBL] [Abstract][Full Text] [Related]
58. Mesenchymal Stromal Cells Are Retained in the Porcine Renal Cortex Independently of Their Metabolic State After Renal Intra-Arterial Infusion.
Sierra-Parraga JM; Munk A; Andersen C; Lohmann S; Moers C; Baan CC; Ploeg RJ; Pool M; Keller AK; Møller BK; Leuvenink H; Hoogduijn MJ; Jespersen B; Eijken M
Stem Cells Dev; 2019 Sep; 28(18):1224-1235. PubMed ID: 31280676
[TBL] [Abstract][Full Text] [Related]
59. Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study.
Detry O; Vandermeulen M; Delbouille MH; Somja J; Bletard N; Briquet A; Lechanteur C; Giet O; Baudoux E; Hannon M; Baron F; Beguin Y
J Hepatol; 2017 Jul; 67(1):47-55. PubMed ID: 28284916
[TBL] [Abstract][Full Text] [Related]
60. Mesenchymal stem cells and immune disorders: from basic science to clinical transition.
Wang S; Zhu R; Li H; Li J; Han Q; Zhao RC
Front Med; 2019 Apr; 13(2):138-151. PubMed ID: 30062557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
